Pharmstandard

Pharmstandard

Pharmstandard

Suggest edits
Follow us
Also headquartered in Moscow
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 4

Portfolio

Portfolio Tracker

Add info
Xconomy

Proteon Therapeutics Plans Path Forward for Blood Vessel Drug

Health
Proteon Therapeutics
Proteon Therapeutics
$102,000,000 IPO
Xconomy

Jounce Gets $102M As Biotech IPOs Gain Steam in ’17

Stock markets Earnings
Jounce Therapeutics
Jounce Therapeutics
$20,000,000 Venture capital (Series C)
Xconomy , FinSMEs

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Funding Health Science
Avelas Biosciences
Avelas Biosciences
$56,000,000 Venture capital (Series B)
VentureWire

The Daily Startup: Jounce Therapeutics Raises $56M as Immunotherapy Stays Hot

Funding